Sponsor or institution
Clinical trials and research at GT Metabolic Solutions, Inc.
As of November 12, 2026, Find a Trial lists 5 clinical trials run by GT Metabolic Solutions, Inc. that are recruiting, at sites in 6 countries (most in Canada (2), Chile (1), Italy (1)). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 5Clinical trials
- 6Countries
Newest trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Gastrointestinal Magnet System for Creating a Gastroenterostomy | — | Prague | Recruiting | May 27, 2026 |
| Creating a temporary bowel connection with the GT Metabolic magnet system. | — | Santiago and 3 other locations | Recruiting | Feb 25, 2026 |
| Side-to-side duodeno-ileostomy with magnets versus semaglutide for adults with obesity and type 2 diabetes | — | Westmount, Quebec | Recruiting | Jan 5, 2026 |
| GT Metabolic Magnet System to create side-to-side connections in the stomach or small intestine | — | Westmount, Quebec | Recruiting | Jan 5, 2026 |
| Registry to assess outcomes of the MagDI System for bowel surgery | — | Ventura, California and 5 other locations | Recruiting | Apr 15, 2025 |
All recruiting trials (5)
-
Gastrointestinal Magnet System for Creating a Gastroenterostomy
This study tests the GT Metabolic Magnet System to see if it can safely create a side-to-side gastroenterostomy for adults with gastric outlet obstruction.
-
Creating a temporary bowel connection with the GT Metabolic magnet system.
This trial will test if the GT Metabolic Magnet System can safely create temporary bowel connections for people needing colorectal or ileocolic anastomoses.
-
Side-to-side duodeno-ileostomy with magnets versus semaglutide for adults with obesity and type 2 diabetes
This trial tests whether a magnet-assisted side-to-side duodeno-ileostomy surgery or the medication semaglutide works better to improve blood sugar control and weight in adults with obesity and type 2 diabetes.
-
GT Metabolic Magnet System to create side-to-side connections in the stomach or small intestine
This study will test whether the GT Metabolic Magnet System can safely create side-to-side connections in the stomach or small intestine for adults with gastric outlet obstruction, partial small bowel obstruction, or superior mesenteric artery syndrome.
-
Registry to assess outcomes of the MagDI System for bowel surgery
This study is trying to see how well the MagDI System works for bowel surgery and if it causes fewer problems like internal hernias and blockages in patients in the U.S. compared to past studies.
Quick answers
How many clinical trials run by GT Metabolic Solutions, Inc. are recruiting right now?
5, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 6 countries. The most sites are in Canada (2 trials), Chile (1 trial), Italy (1 trial), Spain (1 trial), Czechia (1 trial). Each study page lists its sites and which ones are recruiting.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.